Parental presence during treatment of ebola or other highly consequential infection

COMMITTEE ON INFECTIOUS DISEASES

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

This clinical report offers guidance to health care providers and hospitals on options to consider regarding parental presence at the bedside while caring for a child with suspected or proven Ebola virus disease (Ebola) or other highly consequential infection. Options are presented to help meet the needs of the patient and the family while also posing the least risk to providers and health care organizations. The optimal way to minimize risk is to limit contact between the person under investigation or treatment and family members/caregivers whenever possible while working to meet the emotional support needs of both patient and family. At times, caregiver presence may be deemed to be in the best interest of the patient, and in such situations, a strong effort should be made to limit potential risks of exposure to the caregiver, health care providers, and the community. The decision to allow parental/caregiver presence should be made in consultation with a team including an infectious diseases expert and state and/or local public health authorities and should involve consideration of many factors, depending on the stage of investigation and management, including (1) a careful history, physical examination, and investigations to elucidate the likelihood of the diagnosis of Ebola or other highly consequential infection; (2) ability of the facility to offer appropriate isolation for the person under investigation and family members and to manage Ebola; (3) ability to recognize and exclude people at increased risk of worse outcomes (eg, pregnant women); and (4) ability of parent/caregiver to follow instructions, including appropriate donning and doffing of personal protective equipment.

Original languageEnglish (US)
Article numbere20161891
JournalPediatrics
Volume138
Issue number3
DOIs
StatePublished - Sep 1 2016

Fingerprint

Caregivers
Aptitude
Health Personnel
Infection
Ebola Hemorrhagic Fever
Therapeutics
Physical Examination
Communicable Diseases
Pregnant Women
Referral and Consultation
Public Health
History
Organizations
Healthcare
Person

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Medicine(all)
  • Arts and Humanities (miscellaneous)

Cite this

Parental presence during treatment of ebola or other highly consequential infection. / COMMITTEE ON INFECTIOUS DISEASES.

In: Pediatrics, Vol. 138, No. 3, e20161891, 01.09.2016.

Research output: Contribution to journalArticle

COMMITTEE ON INFECTIOUS DISEASES. / Parental presence during treatment of ebola or other highly consequential infection. In: Pediatrics. 2016 ; Vol. 138, No. 3.
@article{e63b4fa655f346c487b580814c00a845,
title = "Parental presence during treatment of ebola or other highly consequential infection",
abstract = "This clinical report offers guidance to health care providers and hospitals on options to consider regarding parental presence at the bedside while caring for a child with suspected or proven Ebola virus disease (Ebola) or other highly consequential infection. Options are presented to help meet the needs of the patient and the family while also posing the least risk to providers and health care organizations. The optimal way to minimize risk is to limit contact between the person under investigation or treatment and family members/caregivers whenever possible while working to meet the emotional support needs of both patient and family. At times, caregiver presence may be deemed to be in the best interest of the patient, and in such situations, a strong effort should be made to limit potential risks of exposure to the caregiver, health care providers, and the community. The decision to allow parental/caregiver presence should be made in consultation with a team including an infectious diseases expert and state and/or local public health authorities and should involve consideration of many factors, depending on the stage of investigation and management, including (1) a careful history, physical examination, and investigations to elucidate the likelihood of the diagnosis of Ebola or other highly consequential infection; (2) ability of the facility to offer appropriate isolation for the person under investigation and family members and to manage Ebola; (3) ability to recognize and exclude people at increased risk of worse outcomes (eg, pregnant women); and (4) ability of parent/caregiver to follow instructions, including appropriate donning and doffing of personal protective equipment.",
author = "{COMMITTEE ON INFECTIOUS DISEASES} and Davies, {H. Dele} and Byington, {Carrie L.} and Maldonado, {Yvonne A.} and {Barnett Md}, {Elizabeth D.} and Edwards, {Kathryn M.} and Ruth Lynfield and Munoz, {Flor M.} and Dawn Nolt and Nyquist, {Ann Christine} and Rathore, {Mobeen H.} and Sawyer, {Mark H.} and Steinbach, {William J.} and Tan, {Tina Q.} and Zaoutis, {Theoklis E.} and Kimberlin, {David W.} and Brady, {Michael T.} and Jackson, {Mary Anne} and Long, {Sarah S.} and Bernstein, {Henry H.} and Meissner, {H. Cody} and Krug, {Steven E.} and Douglas Campos-Outcalt and Farizo, {Karen M.} and Marc Fischer and Gellin, {Bruce G.} and Gorman, {Richard L.} and Natasha Halasa and Robinson, {Joan L.} and Safadi, {Marco Aurelio Palazzi} and Seward, {Jane F.} and Simon, {Geoffrey R.} and Starke, {Jeffrey R.} and Frantz, {Jennifer M.}",
year = "2016",
month = "9",
day = "1",
doi = "10.1542/peds.2016-1891",
language = "English (US)",
volume = "138",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "3",

}

TY - JOUR

T1 - Parental presence during treatment of ebola or other highly consequential infection

AU - COMMITTEE ON INFECTIOUS DISEASES

AU - Davies, H. Dele

AU - Byington, Carrie L.

AU - Maldonado, Yvonne A.

AU - Barnett Md, Elizabeth D.

AU - Edwards, Kathryn M.

AU - Lynfield, Ruth

AU - Munoz, Flor M.

AU - Nolt, Dawn

AU - Nyquist, Ann Christine

AU - Rathore, Mobeen H.

AU - Sawyer, Mark H.

AU - Steinbach, William J.

AU - Tan, Tina Q.

AU - Zaoutis, Theoklis E.

AU - Kimberlin, David W.

AU - Brady, Michael T.

AU - Jackson, Mary Anne

AU - Long, Sarah S.

AU - Bernstein, Henry H.

AU - Meissner, H. Cody

AU - Krug, Steven E.

AU - Campos-Outcalt, Douglas

AU - Farizo, Karen M.

AU - Fischer, Marc

AU - Gellin, Bruce G.

AU - Gorman, Richard L.

AU - Halasa, Natasha

AU - Robinson, Joan L.

AU - Safadi, Marco Aurelio Palazzi

AU - Seward, Jane F.

AU - Simon, Geoffrey R.

AU - Starke, Jeffrey R.

AU - Frantz, Jennifer M.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - This clinical report offers guidance to health care providers and hospitals on options to consider regarding parental presence at the bedside while caring for a child with suspected or proven Ebola virus disease (Ebola) or other highly consequential infection. Options are presented to help meet the needs of the patient and the family while also posing the least risk to providers and health care organizations. The optimal way to minimize risk is to limit contact between the person under investigation or treatment and family members/caregivers whenever possible while working to meet the emotional support needs of both patient and family. At times, caregiver presence may be deemed to be in the best interest of the patient, and in such situations, a strong effort should be made to limit potential risks of exposure to the caregiver, health care providers, and the community. The decision to allow parental/caregiver presence should be made in consultation with a team including an infectious diseases expert and state and/or local public health authorities and should involve consideration of many factors, depending on the stage of investigation and management, including (1) a careful history, physical examination, and investigations to elucidate the likelihood of the diagnosis of Ebola or other highly consequential infection; (2) ability of the facility to offer appropriate isolation for the person under investigation and family members and to manage Ebola; (3) ability to recognize and exclude people at increased risk of worse outcomes (eg, pregnant women); and (4) ability of parent/caregiver to follow instructions, including appropriate donning and doffing of personal protective equipment.

AB - This clinical report offers guidance to health care providers and hospitals on options to consider regarding parental presence at the bedside while caring for a child with suspected or proven Ebola virus disease (Ebola) or other highly consequential infection. Options are presented to help meet the needs of the patient and the family while also posing the least risk to providers and health care organizations. The optimal way to minimize risk is to limit contact between the person under investigation or treatment and family members/caregivers whenever possible while working to meet the emotional support needs of both patient and family. At times, caregiver presence may be deemed to be in the best interest of the patient, and in such situations, a strong effort should be made to limit potential risks of exposure to the caregiver, health care providers, and the community. The decision to allow parental/caregiver presence should be made in consultation with a team including an infectious diseases expert and state and/or local public health authorities and should involve consideration of many factors, depending on the stage of investigation and management, including (1) a careful history, physical examination, and investigations to elucidate the likelihood of the diagnosis of Ebola or other highly consequential infection; (2) ability of the facility to offer appropriate isolation for the person under investigation and family members and to manage Ebola; (3) ability to recognize and exclude people at increased risk of worse outcomes (eg, pregnant women); and (4) ability of parent/caregiver to follow instructions, including appropriate donning and doffing of personal protective equipment.

UR - http://www.scopus.com/inward/record.url?scp=84986000941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84986000941&partnerID=8YFLogxK

U2 - 10.1542/peds.2016-1891

DO - 10.1542/peds.2016-1891

M3 - Article

C2 - 27550981

AN - SCOPUS:84986000941

VL - 138

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 3

M1 - e20161891

ER -